You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CCA

Showing 1 - 25 of 407
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Corpus Callosum Agenesis Trial in Paris (Decision-making process)

Recruiting
  • Corpus Callosum Agenesis
  • Decision-making process
  • Paris, France
    Pitié-Salpêtrière Hospital, AP-HP - Department of Medical Geneti
Apr 24, 2023

Adenoid Hypertrophy Trial (Adenoidectomy with endoscopic assisted coblation (EACA) and Adenoidectomy with conventional curettage

Not yet recruiting
  • Adenoid Hypertrophy
  • Adenoidectomy with endoscopic assisted coblation (EACA) and Adenoidectomy with conventional curettage (CCA)
  • (no location specified)
Mar 20, 2022

Diagnostic Test Trial in Sacramento (Measuring of analytes)

Recruiting
  • Diagnostic Test
  • Measuring of analytes
  • Sacramento, California
    UC Davis
Oct 9, 2023

POC-CCA Rapid Urine Test for Qualitative Detection of

Completed
  • Aged ≥2 Years in Schistosomiasis Affected Areas
  • POC-CCA rapid urine test
  • Donggala, Central Of Sulawesi, Indonesia
    Donggala Research and Development (R&D) Center, Ministry of Heal
Oct 31, 2021

Cholangiocarcinoma (CCA) in Primary Sclerosing Cholangitis (PSC)

Completed
  • Primary Sclerosing Cholangitis
  • Cholangiocarcinoma
  • MR/MRCP
  • Stockholm, Sweden
    Karolinska University Hospital, Huddinge
Sep 8, 2021

Clareon IOL Retrospective Data Collection

Not yet recruiting
  • Aphakia
  • Astigmatism
  • Clareon UVA IOL
  • +2 more
  • Fort Worth, Texas
    Alcon Research, LLC
Mar 22, 2023

The Effect of Trendelenburg Position on CCA Blood Flow

Completed
  • Perfusion
  • Perioperative/Postoperative Complications
    • Seoul, Korea, Republic of
      Jin-Tae Kim
    Jan 17, 2022

    Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

    Recruiting
    • Biliary Tract Cancer (CCA)
    • +4 more
    • Frankfurt am Main, Germany
      Krankenhaus Nordwest
    Jun 23, 2022

    Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

    Active, not recruiting
    • Cholangiocarcinoma
    • +3 more
    • Durvalumab
    • +3 more
    • Hannover, Germany
      Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
    Oct 14, 2021

    Streptococcus Agalactiae Trial (SGB PCR, SGB culture)

    Not yet recruiting
    • Streptococcus Agalactiae
    • SGB PCR
    • SGB culture
    • (no location specified)
    Aug 11, 2021

    Aphakia Trial in United States (Clareon Vivity/Vivity Toric Extended Vision IOL, Clareon/Clareon Toric Aspheric IOL)

    Not yet recruiting
    • Aphakia
    • Clareon Vivity/Vivity Toric Extended Vision IOL
    • Clareon/Clareon Toric Aspheric IOL
    • Torrance, California
    • +6 more
    May 2, 2023

    Precision Medicine for Combined

    Recruiting
    • Liver Cancer
    • phenotyping
    • Créteil, France
      Julien Calderaro
    Nov 17, 2023

    Temporomandibular Disorder, Nonspecific Chronic Neck Pain, Biomechanical Phenomena Trial in Taipei (Cervical range of motion

    Completed
    • Temporomandibular Disorder
    • +2 more
    • Cervical range of motion (CROM)
    • +4 more
    • Taipei, Taiwan
      National Yang-Ming University
    Nov 9, 2020

    Glioma Grading and Genotyping

    Recruiting
    • Glioma
      • Chongqing, Chongqing, China
        Sang Zifan
      Aug 29, 2023

      A Global Record of Anal Squamous Cell Carcinoma With and Without

      Not yet recruiting
      • Anal Squamous Cell Carcinoma
      • HIV Infections
        • (no location specified)
        Nov 28, 2022

        Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

        Not yet recruiting
        • Advanced Cholangiocarcinoma
        • +2 more
        • (no location specified)
        Feb 3, 2023

        Cholangiocarcinoma, Bile Duct Tumor, Biliary Tract Malignancy Trial run by the National Cancer Institute (NCI) (Tivozanib)

        Recruiting
        • Cholangiocarcinoma
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 6, 2022

        Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)

        Not yet recruiting
        • Cholangiocarcinoma
        • Liver Cancer
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 18, 2022

        Atopic Dermatitis Trial in Canada, China (Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active

        Recruiting
        • Atopic Dermatitis
        • Core Treatment Active Experimental: SHR0302 Dose#1
        • +4 more
        • Surrey, British Columbia, Canada
        • +43 more
        Oct 31, 2022

        Hand Eczema Trial in Worldwide (Ruxolitinib cream, Vehicle)

        Withdrawn
        • Hand Eczema
        • Phoenix, Arizona
        • +48 more
        Nov 14, 2022

        Common Bile Duct Tumors, Non-Neoplastic Bile Duct Disorder Trial in Worldwide (AI model classification, DSOC endoscopist

        Active, not recruiting
        • Common Bile Duct Neoplasms
        • Non-Neoplastic Bile Duct Disorder
        • AI model classification
        • DSOC endoscopist experts' classification
        • New Brunswick, New Jersey
        • +5 more
        Mar 30, 2022

        Cholangiocarcinoma Trial in Worldwide (Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemo)

        Active, not recruiting
        • Cholangiocarcinoma
        • Fimaporfin and Gemcitabine
        • Gemcitabine/Cisplatin chemotherapy
        • Duarte, California
        • +49 more
        Mar 4, 2022

        Atopic Dermatitis Trial in Worldwide (LY3454738, Placebo)

        Not yet recruiting
        • Atopic Dermatitis
        • Fort Smith, Arkansas
        • +55 more
        Jun 12, 2023

        Combined Hepatocellular Cholangiocarcinoma Trial (gemcitabine ,oxaliplatin,anlotinib,Sintilimab)

        Not yet recruiting
        • Combined Hepatocellular Cholangiocarcinoma
        • gemcitabine ,oxaliplatin,anlotinib,Sintilimab
        • (no location specified)
        Sep 10, 2023

        Detecting IgG4-related Sclerosing Cholangitis

        Completed
        • IgG4-related Sclerosing Cholangitis
        • IgG4-related Disease
          • Rochester, Minnesota
          • +1 more
          Jan 3, 2022